« Back to Record
Citation APA

Gregson, J., Pillay, D., de Oliveira, T., Clumeck, N., Hunt, G., Kerschberger, B., Shafer, R. R., Yang, C., Raizes, E., Kantor, R., Gupta, R. K., Kaleebu, P., Marconi, V. V., van Vuuren, C., Ndembi, N., Hamers, R. R., Kanki, P., Hoffmann, C. C., & Lockman, S. (2017). Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet. Infectious diseases, 17(3), 296-304. doi:10.1016/S1473-3099(16)30469-8


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/247645

Gregson, J., Pillay, D., de Oliveira, T., Clumeck, N., Hunt, G., Kerschberger, B., Shafer, R. R., Yang, C., Raizes, E., Kantor, R., Gupta, R. K., Kaleebu, P., Marconi, V. V., van Vuuren, C., Ndembi, N., Hamers, R. R., Kanki, P., Hoffmann, C. C., & Lockman, S. (2017). Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. Lancet. Infectious diseases, 17(3), 296-304. doi:10.1016/S1473-3099(16)30469-8